Patent details

EP1636185 Title: NOVEL CRYSTALLINE FORMS OF PERINDOPRIL ERBUMINE

Basic Information

Publication number:
EP1636185
PCT Application Number:
PCT/CH/2004/000374
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047370291
PCT Publication Number:
WO/2004/113293
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
NOVEL CRYSTALLINE FORMS OF PERINDOPRIL ERBUMINE
French Title of Invention:
NOUVELLES FORMES CRISTALLINES DE PERINDOPRIL ERBUMINE
German Title of Invention:
NEUE KRISTALLINE FORMEN VON PERINDOPRIL ERBUMINE
SPC Number:

Dates

Filing date:
18/06/2004
Grant date:
11/01/2012
EP Publication Date:
11/01/2012
PCT Publication Date:
29/12/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/03/2006
EP B1 Publication Date:
11/01/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/06/2019
Expiration date:
18/06/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/05/2012
 
 

Name:
Les Laboratoires Servier
Address:
35, rue de Verdun, 92284 Suresnes Cedex, France (FR)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
28/03/2012
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
FÄSSLER Roger
Address:
Switzerland (CH)

2

Name:
LELLEK Vit
Address:
Switzerland (CH)

3

Name:
STRÄSSLER Christoph
Address:
Switzerland (CH)

Priority

Priority Number:
110903
Priority Date:
24/06/2003
Priority Country:
Switzerland (CH)

Classification

Main IPC Class:
C07D 209/42;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/06/2018
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages